Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Look,
I personally dont think that https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6
was offered to NEJM by Liau, Ashkan and Bosch before for the simple reason that NEJM is not particularly fond of publishing interim blinded trials.
Bosch only published 4 times before https://www.biomedcentral.com/search?query=author%23%22Marnix%20L.+Bosch%22 none of them were in NEJM
I cant rule out the account was created prior to submitting the DCVAX L article but I hardly doubt it. So there is no guarantee as with many many posts here as have your posts no guarantee.
Also, Dr Liau probably submitted the article. But the NEJM author-center offers the option to assign co-authors to work on the article together and after. I think that is what happened here.
with his NWBO email thus under an NWBO account?
Could be to submit what?
I suspect all three (Ashkin, LL, and Bosch) have an account and work on it simultaneously
I haven't gotten around that to do so, but here is the problem in that thesis. LL has submitted in NEJM before so that would not prove it's for the one we are all waiting for? with MB I don't have that problem
by all means go ahead
I wanted to find out if NWBO had indeed submitted a manuscript with NEJM for sure. Then I thought of a simple plan to determine this. I visited The NEJM Author Center where authors can register to submit manuscripts with NEJM which can be found here:
https://www.nejm.org/author-center/home
I have zero hopes of BLA already being submitted. Hell if anything I would over the moon happy with just TLD at this point.
I think this whole talk about BLA is silly as long as we have not seen TLD ( and a publication)
But yes it would be an incredible waste of time if NWBO had not worked on a BLA
that is also true.
NWBO would be a world-first where BLA submission would proceed TLD announcement
I think its highly unlikely but I hope Im wrong
yes I agree
I got the same reply
DD this is how I see it what happened
Scenario 1
1. We know that the conference presentation was never meant to be held prior to TLD + Publication so during the quiet time.
=> Bosch must have been receiving many emails from the conference months prior and right up till the conference. So the conference and his responsibility for his attendance must have been on his mind all that time. Therefore if he knew weeks before the start of the conference that TLD + Publication would take a long time he would have canceled weeks before.
2. On Monday, January 10 MB was made aware by either email or a phone call from the event manager that his time of appearance had been shifted for Jan 20 from 11..40 to 12.10.
you are probably right. Im going to do a bit more research and think this over
thanks for all your great research DD
One thing Im convinced about the conference was supposed to be after results had been disclosed. There is just no way NWBO will present anything in their quiet period. I think it was kinda not on MB's radar when he got the email Thursday, got reminded, and canceled.
MB is definitely a co-author as he was in May 2018.
That to me indicates and I'm speculation now I realize that, that they still have not a definite publication date. Could be peer-reviewing which I suspect could be the last details.. we don't know where they are .
mmmmmm
https://glioblastoma-drugdevelopment.com/virtual-event-faqs/#speaker
at what point will NWBO get a name for constantly pulling out of conferences? Seriously. This must be a huge nuisance to the glioblastoma-drugdevelopment conference organization they pulled out 4 days before it started, people are paying admittance.
ooh yeah, it happens that people forget its the other way around.
The same for crypto as in Casinos always place your money on the color or number where the ball will fall on next, people seem to forget that simple rule lol
wrong
NWBO needs continuous FDA permission to sell DCVAX L as compassionate treatment, which we know for a few days now is exactly what they are doing, has just started up, in Sawston. FDA has seen the data for sure, combine the two and you know what time it is.
that is correct
Moreover, the FDA and the MHRA have permitted the continuation of the compassionate sales of DCVAX L in Sawston after the FDA has become aware of the unblinded data. It would be beyond bizarre if in the near future the FDA would turn around and disapprove DCVAXL after the BLA is submitted.
you can only say that you are glad that you didnt invest all after topline data+publication or am I wrong?
Your explanation makes sense. If the presentation was always intended prior to TLD / journal as we have seen Dr Liau's last year then they would have not canceled. Something very short notice came up so they had to cancel and if I had to guess it is NEJM letting NWBO know they had to move the publication to another time frame.
Exactly
You have to give Bosch a bit more credit then that he would not have confounded the trial results, he is NWBOs CTO and co author!
Let’s say they planned max 2 weeks between TLD and the journal and Bosch just after TLD. It would not surprise me if NEJM called them yesterday and told them they have to move the publication to half feb. In that case it would leave them no choice to cancel Bosch. If the publication were not ready yet then they would have known that weeks ago and cancelled a lot sooner. IMO
well I dont want to be negative but how much time before the placeholder was canceled for the dr Liau talk in nov 2020? 3,4 days?
Thanks that is true
mmm it could also be a small hick up with NEJM and not with NWBO this time
yup I think scenario 1 is most likely for peat sake let it be a small delay
looks like it, freaking unbelievable
jeeezzzzzzzzzz
yes he pulled out
https://glioblastoma-drugdevelopment.com/speaker/marnix-bosch-2/
Title and time now stripped from his speaking slot.
another placeholder removed?